Massivemarkets

WST

West Pharmaceutical Services, Inc.

NYSE · usd

$392.15-1.88 (-0.48%)
At close · 15-minute delayed
$392.00-0.15 (-0.04%)
As of 7:43:44 PM EDT on Oct 23, 2026 · After hours

West Pharmaceutical Services, Inc. (WST) trades at $392.15 (-0.48%) as of 7:43:44 PM EDT on Oct 23, 2026, +4.97% over the past month. Market cap is $27.73B, with 3.1 days to cover in short interest.

Stock performance

How West Pharmaceutical Services, Inc. (WST) stock has performed from one day to one year, with its 52-week range.

-0.15%
-$0.57 over 1D
$390.00$391.22$392.44$393.669:30 AM11:10 AM12:50 PM2:25 PM8:00 PM$391.09
1D
-0.48%
1W
+2.12%
1M
+4.97%
YTD
+42.53%
1Y
+36.53%
52-wk range
$223.83 – $397.16

Key statistics

Today's trading snapshot for WST: day range, open, previous close, volume and market cap.

Day range
$389.72 – $394.18
Open
$391.60
Prev close
$394.03
Volume
718.05K
Market cap
$27.73B
Shares out
70.38M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for West Pharmaceutical Services, Inc.: P/E, P/S, P/B, ROE and more.

P/E
49.09
P/S
8.34
P/B
9.27
P/FCF
63.47
ROE
18.9%
ROA
13.9%
Debt/Equity
0.07
Div yield
0.21%

As of Oct 22, 2026

8-K filings

Material corporate events West Pharmaceutical Services, Inc. has disclosed to the SEC on Form 8-K.

  • Deal agreementsJul 14, 2026

    The Crosslicense Agreement permits each party to license the other's know-how, patents and trademarks in the manufacture, use and sale of those products. Daikyo's license from West is non-exclusive and West's license from Daikyo is exclusive outside of Japan subject to certain limited exceptions. The Crosslicense Agreement is royalty-free except for a fixed royalty rate that is generally applicable to the licensing of certain patents and non-patented technical information.

  • Executive leadershipJun 1, 2026

    On June 1, 2026, the Company announced the appointment of Michel Lagarde as President and Chief Executive Officer of the Company, effective August 31, 2026 (the "Start Date"), to replace Mr. Green in those roles. Mr. Lagarde, 52, has served as Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific, Inc., with responsibility for the majority of the company's businesses.

  • Security and safetyMay 11, 2026

    On May 7, 2026, West Pharmaceutical Services, Inc. (the "Company") determined that the Company has experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems were encrypted. Upon initial detection of an intrusion on May 4, 2026, the Company promptly activated its incident response protocols, including proactively taking systems offline globally for containment purposes, notifying law enforcement, and engaging external cyber-forensic experts.

  • Shareholder activismMay 5, 2026

    The shareholder proposal regarding an Independent Board Chair Policy was not approved with 29,592,488 votes for, 34,245,125 against, 112,824 abstentions, and 2,242,885 broker non-votes.

  • Executive leadershipMar 9, 2026

    Mr. Eric M. Green, President, Chief Executive Officer and Chair of the Board of Directors (the "Board) of the Company, informed the Board on March 6, 2026 of his intent to retire from those positions once his successor has been hired in order to ensure a smooth transition. The Board is engaging a leading executive recruiting firm to assist with the search for a successor and expects this transition to occur in the second half of 2026.

Dividend history and stock splits

West Pharmaceutical Services, Inc.'s recent dividend payments and stock splits.

Dividends

  • $0.26ex-div Nov 10, 2026
  • $0.22ex-div Jul 29, 2026
  • $0.22ex-div Apr 29, 2026
  • $0.22ex-div Jan 28, 2026

Splits

  • 2-for-1Sep 27, 2013
  • 2-for-1Sep 30, 2004

WST short interest

How heavily WST is shorted: shares short, days to cover and average daily volume.

Days to cover
3.1
Short interest
2.1M
Avg volume
674.54K

As of · reported to FINRA twice monthly.

WST news

The latest news and headlines about West Pharmaceutical Services, Inc. (WST).

Frequently asked questions

What is the West Pharmaceutical Services, Inc. (WST) stock price today?

West Pharmaceutical Services, Inc. (WST) is trading at $392.15 (-0.48% on the day) as of 7:43:44 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is West Pharmaceutical Services, Inc.?

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and…

What is the short interest in WST?

As of Sep 30, 2026, WST has 2.1M shares short and 3.1 days to cover.

Does West Pharmaceutical Services, Inc. (WST) pay a dividend?

Yes. West Pharmaceutical Services, Inc. (WST)'s most recent dividend was $0.26 per share, with an ex-dividend date of Nov 10, 2026. Full WST dividend history is available from the Massive API.

What exchange is WST listed on?

West Pharmaceutical Services, Inc. (WST) trades on NYSE in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

Build with AI

Build an analysis of WST with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a WST analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Want the most up-to-date, real-time data? Connect to the Massive API and MCP server — the source behind every number on this page — covering stocks, options, indices, currencies and futures. Docs: https://massive.com/docs/rest. Get a free API key.

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.